On the recordApril 27, 2022
The accelerated approval pathway has been successful in ensuring patient access to new medications, and has been especially effective for patients with cancer.
Source
congress.govEditor's note · Context
Roy Blunt highlights the success of the accelerated approval pathway for cancer medications.
Share
More from Roy Blunt
Sep 26, 2022
Through the strong, bipartisan action of this Subcommittee's leaders, Chairman Roy Blunt and Ranking Member Patty Murray, Congress is helping the agency regain lost ground after years of effectively flat budgets.
Dec 14, 2022
in calculating, it may be possible that I have served on the Intel Committee longer than anybody besides Richard Burr currently on the committee, with some time in the House--but not all of the time in the House--and in the Senate. It is…
Jul 27, 2022
I am glad to join you and the other Senator from Georgia, Mr. Ossoff, here today and join both of you in sharing some thoughts about Senator Isakson. Senator Ossoff has already said a lot of things that are easily said. Not that they were…
Other voices in this conversation
